ÂÜÀòÂÒÂ×

Jeff Wunderlich is a seasoned professional in market access and payer management with extensive experience in the pharmaceutical industry. Currently serving as Senior Director of Market Access Payer & PBM at Incyte since May 2020, Wunderlich focuses on market access strategy and managing key accounts within hematology, oncology, and immunology. Prior to Incyte, significant roles included leadership positions at Celgene, where Jeff developed national trade strategies and managed payer accounts, receiving the Celgene President's Club Award in 2017. Additional roles include Director of Sales at Avella Specialty Pharmacy, brand management at Chelsea Therapeutics, and various positions at Amgen, where multiple awards were achieved for performance excellence across marketing and sales. Wunderlich holds a Bachelor of Science degree in Nutrition from The University of Texas at Austin.